Skip to content
Screener

CareDx CDNA Q4 2025 Annual earnings

Reported February 24, 2026 · After market close

Revenue$108.4MBeat by $5.1M
EPS-$0.08Miss by $0.10
Revenue estimate$103.3M
EPS estimate$0.02

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$121.9M
EPS estimate$0.24

Financials

Q4 2025

Income statement

See full
Revenue$108.4M+25.2%
Operating income-$6.0M-107%
Net income-$4.1M-105%
EPS (diluted)-$0.08-105%

Balance sheet

See full
Cash & equivalents$66.0M-42.8%
Total debt$26.2M-7.7%
Total equity$303.1M-19.9%
Total assets$413.2M-15.8%

Cash flow

See full
Operating cash flow$21.4M-2.4%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$968.99M-15.6%
Enterprise value$929.2M-12.5%
P/S2.6×-0.9×

Profitability

See full
Operating margin-8.1%-20.3pp
Net margin-5.6%-21.4pp

Returns & leverage

See full
Return on equity-6.3%-22.7pp
Debt / equity0.1×0.0×
Current ratio2.9×-1.1×

Segments

By product

See full
Testing services revenue$78.4M+22.8%
Patient and digital solutions revenue$16.8M+47.1%

By segment

See full
Reportable Segment$108.4M+25.2%

FAQ

When did CareDx report Q4 2025 earnings?
CareDx (CDNA) reported Q4 2025 earnings on February 24, 2026 after market close.
What were CareDx's Q4 2025 revenue and EPS?
CareDx reported revenue of $108.4M and eps of $-0.08 for Q4 2025.
Did CareDx beat estimates in Q4 2025?
Revenue beat the consensus estimate of $103.3M by $5.1M. EPS missed the consensus estimate of $0.02 by $0.10.
How did CareDx's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 25.2% from $86.6M a year earlier.
Where can I find CareDx's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001217234-26-000015) and the 10-K periodic report (0001217234-26-000018) directly on SEC EDGAR. The filing index links above go to sec.gov.